This is the most consequential myth in tobacco culture — because it is experientially real while being pharmacologically false. Smoking does relieve anxiety. But the anxiety it relieves is the anxiety caused by nicotine withdrawal between cigarettes. Non-smokers have measurably lower baseline anxiety than smokers. The "stress relief" of a cigarette is the removal of a withdrawal-induced discomfort — creating the illusion of a net positive effect when the actual net effect on anxiety is negative.

After completing withdrawal — typically 2–4 weeks after quitting — former smokers consistently report lower anxiety levels than when they were smoking. Multiple studies across different populations confirm this. The stress relief of smoking is real. The source of that stress is also smoking.

Quitting at any age produces measurable, clinically significant health improvements. A 60-year-old who quits has a 50% lower risk of dying from smoking-related causes than one who continues. Blood pressure normalises within 20 minutes of the last cigarette at any age. Lung function improves within weeks at any age. Cardiovascular disease risk begins falling within the first year at any age.

The "it's too late" belief is one of the most dangerous myths in cessation — precisely because it provides a reason not to try that feels logical while being factually wrong. The body's healing mechanisms do not switch off with age or duration. They begin working the moment smoking stops.

This myth is among the most dangerous for low-frequency smokers — because it provides false reassurance that prevents cessation. A BMJ meta-analysis found that smoking just one cigarette per day carries approximately 53% of the cardiovascular risk of smoking 20 per day — not 5%. The dose-response relationship for tobacco's cardiac effects is not linear. Additionally, DNA damage from tobacco carcinogens occurs with each exposure regardless of frequency. The WHO's position is unambiguous: there is no safe level of tobacco use.

Light smokers also dramatically underestimate their nicotine dependency — typically discovering it only when they attempt to quit and find the cravings more intense than expected.

The first part is true: most quitters gain 4–5 kg in the first year after quitting, driven by nicotine's metabolism-boosting effect being removed and by improved appetite from taste recovery. The second part is false as a health argument. The health risks of the average post-quit weight gain are dramatically smaller than the health benefits of quitting tobacco. A 5 kg weight gain does not meaningfully increase the risk of lung cancer, COPD, cardiovascular disease, or any of the primary tobacco-related killers. Continuing to smoke to avoid weight gain is a health trade that consistently goes the wrong way.

Failed quit attempts are evidence of addiction — not of character weakness. The average successful quitter makes 8–14 attempts before achieving lasting cessation. Relapse is a pharmacological feature of addiction — the brain's restructured reward system does not give up its dependence without resistance. Every failed attempt provides information: what triggers are strongest, what support is missing, what approach needs to change.

The myth of willpower as the primary success factor is itself one of the most harmful beliefs in cessation — because it causes people to blame themselves rather than adjust their approach. Method matters far more than willpower. Each failed attempt is not a referendum on character. It is data about what the next attempt needs to do differently.

This is the most common relapse trigger among people who have successfully quit for weeks or months. The belief that "one cigarette is safe" is specifically produced by the addicted brain as it seeks a pathway back to nicotine. Nicotinic receptors — which have been down-regulating toward normal since cessation — retain "memory" of their previous upregulated state. A single cigarette reactivates this system with disproportionate speed — particularly in people who have built months of sobriety. Most people who relapse from this point describe returning to their previous smoking level within days.

Herbal cigarettes contain no tobacco and no nicotine — but they produce smoke. And smoke, regardless of source material, contains carbon monoxide, particulate matter, and combustion byproducts that damage airways and cardiovascular tissue. Studies of herbal cigarette smoke show chemical profiles comparable to tobacco smoke for many harmful compounds. They also maintain the behavioural habit loop of smoking — keeping the cue-response pattern active while providing no pharmacological bridge to cessation. They are neither safe nor effective as a cessation tool.

This myth — cousin to "it's too late to quit" — focuses on reversal rather than progression. Even where reversal is incomplete, quitting stops the damage from compounding further. For conditions like COPD, quitting is the only intervention that slows progression — no medication does this as effectively. Lung function improves up to 30% within 3 months. Heart attack risk falls 50% within 1 year. Oral cancer risk falls measurably within years of cessation. The body has remarkable healing capacity — and even where full reversal is not possible, stopping the damage is both possible and meaningful.

Nicotine is addictive but is not the primary carcinogen in cigarettes — combustion products (tar, carbon monoxide, polycyclic aromatic hydrocarbons) are responsible for most of the cancer and cardiovascular risk. So vaping, which eliminates combustion, does reduce exposure to many of these compounds for existing smokers. However: vaping products contain nicotine (often at higher concentrations), heavy metals (nickel, tin, lead), diacetyl (linked to popcorn lung), and other compounds whose long-term effects are not fully characterised after only ~15 years of population exposure. For non-smokers and young people, vaping carries real risks. For existing smokers, switching completely may reduce harm — but is not risk-free.

Genetics plays a role in cancer susceptibility — but tobacco exposure is the dominant driver of tobacco-related cancer, not genetics. Approximately 85% of lung cancer cases are attributable to smoking. Non-smokers who develop lung cancer represent the exception — not a comparable risk. The genetic argument is often used by smokers to rationalise continuing — "my grandfather smoked till 90 and was fine." This survivorship bias ignores the statistical reality: smokers who don't get cancer are the exception, not the rule. And even they suffer measurably worse cardiovascular and respiratory outcomes.